Botulinum toxin type-A in the management of spastic equinovarus deformity after stroke

References

1. ↵
   1. World Health Organization

   (2013) The top 10 causes of death (WHO, Geneva (CH)) Available from: http://www.who.int/mediacentre/factsheets/fs310/en.
2. ↵
   1. Sommerfeld DK,
   2. Eek EU,
   3. Svensson AK,
   4. Holmqvist LW,
   5. von Arbin MH

   (2004) Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke 35, 134–139.
3. ↵
   1. Ward AB

   (2012) A literature review of the pathophysiology and onset of post-stroke spasticity. Eur J Neurol 19, 21–27.
4. ↵
   1. Daroff RB,
   2. Mazziotta JC

   , eds (2012) Neurology in Clinical Practice (Elsevier Health Sciences, Philadelphia (PA)), 6th ed, 1.
5. ↵
   1. Dajpratham P,
   2. Kuptniratsaikul V,
   3. Kovindha A,
   4. Kuptniratsaikul PS,
   5. Dejnuntarat K

   (2009) Prevalence and management of poststroke spasticity in Thai stroke patients: a multicenter study. J Med Assoc Thai 92, 1354–1360.
6. ↵
   1. Gallichio JE

   (2004) Pharmacologic management of spasticity following stroke. Phys Ther 84, 973–981.
7. ↵
   1. Ozcakir S,
   2. Sivrioglu K

   (2007) Botulinum toxin in poststroke spasticity. Clin Med Res 5, 132–138.
8. ↵
   1. Reichel G

   (2001) Botulinum toxin for treatment of spasticity in adults. J Neurol 248, Suppl 1, 25–27, Review.
9. ↵
   1. Dobkin BH,
   2. Landau WM,
   3. Sahrmann S,
   4. Thomas Thach W,
   5. Simpson DM,
   6. Gracies JM,
   7. et al.

   (2009) Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Neurology 73, 736.
10. ↵
    1. Richardson D,
    2. Sheean G,
    3. Werring D,
    4. Desai M,
    5. Edwards S,
    6. Greenwood R,
    7. et al.

    (2000) Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J Neurol Neurosurg Psychiatry 69, 499–506.
11. ↵
    1. Al-Shahrani AM

    (2003) Anti-spasticity medications. Neurosciences (Riyadh) 8, 8–11.
12. ↵
    1. Sätilä H,
    2. Iisalo T,
    3. Pietikäinen T,
    4. Seppänen RL,
    5. Salo M,
    6. Koivikko M,
    7. et al.

    (2005) Botulinum toxin treatment of spastic equinus in cerebral palsy: a randomized trial comparing two injection sites. Am J Phys Med Rehabil 84, 355–365.
13. ↵
    1. Francisco GE,
    2. McGuire JR

    (2012) Poststroke spasticity management. Stroke 43, 3132–3136.
14. ↵
    1. Foley N,
    2. Murie-Fernandez M,
    3. Speechley M,
    4. Salter K,
    5. Sequeira K,
    6. Teasell R

    (2010) Does the treatment of spastic equinovarus deformity following stroke with botulinum toxin increase gait velocity? A systematic review and meta-analysis. Eur J Neurol 17, 1419–1427.
15. ↵
    1. Pittock SJ,
    2. Moore AP,
    3. Hardiman O,
    4. Ehler E,
    5. Kovac M,
    6. Bojakowski J,
    7. et al.

    (2003) A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis 15, 289–300.
16. ↵
    1. Rousseaux M,
    2. Compère S,
    3. Launay MJ,
    4. Kozlowski O

    (2005) Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles. J Neurol Sci 232, 51–57.
17. ↵
    1. Isoyama H,
    2. Takeuchi N

    (2013) Overview of botulinum toxin as a treatment for spasticity in stroke patients. World J Neurol 3, 133–137.
18. ↵
    1. Takekawa T,
    2. Kakuda W,
    3. Taguchi K,
    4. Ishikawa A,
    5. Sase Y,
    6. Abo M

    (2012) Botulinum toxin type A injection, followed by home-based functional training for upper limb hemiparesis after stroke. Int J Rehabil Res 35, 146–152.
19. ↵
    1. Sheean G

    (2006) Botulinum toxin treatment of adult spasticity: a benefit-risk assessment. Drug Saf 29, 31–48.
20. ↵
    1. Francis HP,
    2. Wade DT,
    3. Turner-Stokes L,
    4. Kingswell RS,
    5. Dott CS,
    6. Coxon EA

    (2004) Does reducing spasticity translate into functional benefit? An exploratory meta-analysis. J Neurol Neurosurg Psychiatry 75, 1547–1551.
21. ↵
    1. Fock J,
    2. Galea MP,
    3. Stillman BC,
    4. Rawicki B,
    5. Clark M

    (2004) Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury. Brain Inj 18, 57–63.
22. 1. Yaşar E,
    2. Tok F,
    3. Safaz I,
    4. Balaban B,
    5. Yilmaz B,
    6. Alaca R

    (2010) The efficacy of serial casting after botulinum toxin type A injection in improving equinovarus deformity in patients with chronic stroke. Brain Inj 24, 736–739.
23. ↵
    1. Farina S,
    2. Migliorini C,
    3. Gandolfi M,
    4. Bertolasi L,
    5. Casarotto M,
    6. Manganotti P,
    7. et al.

    (2008) Combined effects of botulinum toxin and casting treatments on lower limb spasticity after stroke. Funct Neurol 23, 87–91.